| Literature DB >> 6423265 |
A G Cockburn, D Vugrin, M Batata, S Hajdu, W F Whitmore.
Abstract
Anaplastic seminoma constitutes approximately 17% of total experience with seminoma at Memorial Sloan-Kettering Cancer Center. Among 25 previously untreated patients, 11 (44%) were clinical Stage I, and 14 (56%) were clinical Stage II or III. Treatment of these 25 patients with the same regimens employed for classical seminoma yielded an overall 80% 5-year apparent cure rate. Survival rates were poor in eight previously treated patients referred with recurrence.Entities:
Mesh：
Year: 1984 PMID： 6423265 DOI： 10.1002/1097-0142(19840501)53:9<1991::aid-cncr2820530931>3.0.co;2-6
Source DB: PubMed Journal: Cancer ISSN： 0008-543X Impact factor: 6.860